Minerva Neurosciences (NERV) Financials

$4.43

$-0.26 (-5.54%)

As on 04-Sep-2026 16:01EDT

Market cap

$212 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.00	0.01	0.02	0.03	0.01	0.10
Gross Profit	0.00	-0.01	-0.02	-0.03	-0.01	-0.10
Operating Expenses	35.14	15.10	21.85	23.12	25.23	45.37
Operating Profit (EBIT)	-35.14	-15.10	-21.85	-23.12	-25.23	-45.37
Other Income	--	--	--	--	--	--
Profit before Tax	-394.35	-293.42	1.44	-30.01	-32.11	-51.71
Provision for Tax	--	--	--	0.00	6.88	-1.80
Profit after Tax (Net Income)	-394.35	-293.42	1.44	-30.01	-32.11	-49.91
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-32.11	-49.91

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-201.56	-140.75	-25.69	-28.46	-20.02	7.98
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	292.69	236.43	60.00	82.02	73.73	66.33
Current Liabilities	3.96	2.29	2.84	3.34	1.38	2.82
Total Liabilities	99.05	97.97	37.14	56.90	55.09	77.12

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	15.36	14.87	14.87	14.90	14.93	14.92
Current Assets	79.73	83.10	22.27	42.00	40.16	62.20
Total Assets	99.05	97.97	37.14	56.90	55.09	77.12
Total Debt*	71.74	64.96	60.00	82.02	73.73	--
Net Current Assets	75.77	80.81	19.43	38.66	38.78	59.38

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-13,510.94	-19.55	-14.78	-24.65	-24.60
Cash Flow from Investing Activities	--	--	--	--	-0.02	-0.02
Cash from Financing Activities	--	74,450.74	--	19.60	0.00	60.00
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-28.51	-26.39	0.19	-4.61	-6.01	-9.35
Cash EPS ($)	--	-26.39	0.19	-4.61	-6.01	-9.33
Adjusted Book Value ($)	--	--	--	--	--	1.49
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1,215.23	-2.58	-2.27	-4.62	-4.61
Free Cash Flow per Share ($)	--	-1,215.23	-2.58	-2.27	-4.62	-4.61

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	1,414.79	3.28	-55.94	-104.10	-164.30
ROE (%)	--	352.58	-5.31	123.78	532.99	-164.60
ROA (%)	-597.52	-434.34	3.06	-53.59	-48.57	-74.07
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	-1.00
EBIT Growth (%)	-2,774.19	-4,989.50	127.63	12.06	45.57	-2,438.29
Net Profit Growth (%)	-3,611.70	-20,492.68	104.80	6.55	35.66	-2,671.15
EPS Growth (%)	-2,021.81	-139.83	1.04	0.23	0.36	-26.23
Book Value Growth (%)	39.94	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.15	11.69	-1.33	-0.26	-0.09
Price / Book Value	2.68	-0.32	-0.65	-1.41	-0.42	0.54
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	2.60	-0.09	9.19	-3.74	-1.87	1.25
Close Price ($)	5.55	4.02	2.22	6.15	1.59	6.41
High Price ($)	12.46	12.46	13.49	13.22	15.27	30.00
Low Price ($)	1.57	1.15	2.06	1.36	1.26	6.30
Market Cap ($ Cr)	211.52	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-0.46	-2.34	-2.88	-3.68	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	20.14	36.29	7.85	12.57	29.15	22.07
Quick Ratio	20.14	--	--	--	31.34	--
Interest Coverage	--	--	1.32	-2.62	-3.33	-7.17

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	-35,570.29	-129,453.64	--
Payable days	--	75,400.57	27,741.74	16,357.30	60,557.83	5,111.38
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.